The SARS-CoV-2 strain was isolated in NIV and transferred to Bharat Biotech, which has developed the indigenous, inactivated vaccine at its biosafety level-3 (BSL-3) high containment facility located in Genome Valley in Hyderabad outskirts.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2BkRwjL
via IFTTT
0 comments:
Post a Comment